Solriamfetol for the treatment of daytime sleepiness in obstructive sleep apnea
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Solriamfetol for the treatment of daytime sleepiness in obstructive sleep apnea
Authors
Keywords
-
Journal
Expert Review of Respiratory Medicine
Volume 12, Issue 12, Pages 1007-1019
Publisher
Informa UK Limited
Online
2018-10-27
DOI
10.1080/17476348.2018.1541742
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Medical Cannabis and the Treatment of Obstructive Sleep Apnea: An American Academy of Sleep Medicine Position Statement
- (2018) Kannan Ramar et al. Journal of Clinical Sleep Medicine
- Characterization of the Neurochemical and Behavioral Effects of Solriamfetol (JZP-110), a Selective Dopamine and Norepinephrine Reuptake Inhibitor
- (2018) Michelle G. Baladi et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- 0620 A Long-Term Safety and Maintenance of Efficacy Study of Solriamfetol (JZP-110) in the Treatment of Excessive Sleepiness in Subjects with Narcolepsy or Obstructive Sleep Apnea
- (2018) A Malhotra et al. SLEEP
- 0622 Solriamfetol (JZP-110) in the Treatment of Excessive Sleepiness in Narcolepsy and Obstructive Sleep Apnea: Maintenance of Wakefulness Test Results Across the Day
- (2018) P K Schweitzer et al. SLEEP
- 1085 US Healthcare Claims Analysis of Obstructive Sleep Apnea Comorbidities and Their Association with Stimulant Drug Use
- (2018) M M Ohayon et al. SLEEP
- Personalizing sleep apnea care
- (2018) Vishesh K Kapur SLEEP
- Changing Faces of Obstructive Sleep Apnea: Treatment Effects by Cluster Designation in the Icelandic Sleep Apnea Cohort
- (2018) Grace W Pien et al. SLEEP
- 0620 A Long-Term Safety and Maintenance of Efficacy Study of Solriamfetol (JZP-110) in the Treatment of Excessive Sleepiness in Subjects with Narcolepsy or Obstructive Sleep Apnea
- (2018) A Malhotra et al. SLEEP
- 0622 Solriamfetol (JZP-110) in the Treatment of Excessive Sleepiness in Narcolepsy and Obstructive Sleep Apnea: Maintenance of Wakefulness Test Results Across the Day
- (2018) P K Schweitzer et al. SLEEP
- 1085 US Healthcare Claims Analysis of Obstructive Sleep Apnea Comorbidities and Their Association with Stimulant Drug Use
- (2018) M M Ohayon et al. SLEEP
- Personalizing sleep apnea care
- (2018) Vishesh K Kapur SLEEP
- Changing Faces of Obstructive Sleep Apnea: Treatment Effects by Cluster Designation in the Icelandic Sleep Apnea Cohort
- (2018) Grace W Pien et al. SLEEP
- Obesity, Hypersomnolence, and Quality of Sleep: the Impact of Bariatric Surgery
- (2017) Thisciane Ferreira Pinto et al. OBESITY SURGERY
- Does remote monitoring change OSA management and CPAP adherence?
- (2017) Jean L. Pépin et al. RESPIROLOGY
- 1027 AN OPEN-LABEL, SINGLE-DOSE, PHASE 1 STUDY OF THE PHARMACOKINETICS AND SAFETY OF JZP-110 IN SUBJECTS WITH NORMAL OR IMPAIRED RENAL FUNCTION AND WITH END-STAGE RENAL DISEASE REQUIRING HEMODIALYSIS
- (2017) K Zomorodi et al. SLEEP
- 0642 A PHASE 3, RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND, MULTICENTER, 12-WEEK STUDY OF THE SAFETY AND EFFICACY OF JZP-110 IN THE TREATMENT OF EXCESSIVE SLEEPINESS IN PATIENTS WITH OBSTRUCTIVE SLEEP APNEA: SF-36 AND EQ-5D-5L MEASURES
- (2017) H Benes et al. SLEEP
- 0638 FUNCTION AND WORK PRODUCTIVITY MEASURES IN A PHASE 3, RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND, MULTICENTER, 12-WEEK STUDY OF THE SAFETY AND EFFICACY OF JZP-110 FOR THE TREATMENT OF EXCESSIVE SLEEPINESS IN PATIENTS WITH OBSTRUCTIVE SLEEP APNEA
- (2017) R Bogan et al. SLEEP
- 0644 A PHASE 3, PLACEBO-CONTROLLED, RANDOMIZED-WITHDRAWAL, DOUBLE-BLIND, 6-WEEK MULTICENTER STUDY OF THE SAFETY AND EFFICACY OF JZP-110 FOR THE TREATMENT OF EXCESSIVE SLEEPINESS IN PARTICIPANTS WITH OBSTRUCTIVE SLEEP APNEA
- (2017) PJ Strollo et al. SLEEP
- 0641 A PHASE 3, RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND, 12-WEEK, MULTICENTER STUDY OF THE EFFICACY AND SAFETY OF JZP-110 FOR THE TREATMENT OF EXCESSIVE SLEEPINESS IN PATIENTS WITH OBSTRUCTIVE SLEEP APNEA
- (2017) PK Schweitzer et al. SLEEP
- Pharmacotherapy of Apnea by Cannabimimetic Enhancement, the PACE Clinical Trial: Effects of Dronabinol in Obstructive Sleep Apnea
- (2017) David W Carley et al. SLEEP
- Evaluation of the effect of JZP-110 in patients with narcolepsy assessed using the Maintenance of Wakefulness Test censored to 20 minutes
- (2017) Chad Ruoff et al. SLEEP MEDICINE
- Continuous positive airway pressure therapy in obstuctive sleep apnea: benefits and alternatives
- (2017) Michelle T. Cao et al. Expert Review of Respiratory Medicine
- 1027 AN OPEN-LABEL, SINGLE-DOSE, PHASE 1 STUDY OF THE PHARMACOKINETICS AND SAFETY OF JZP-110 IN SUBJECTS WITH NORMAL OR IMPAIRED RENAL FUNCTION AND WITH END-STAGE RENAL DISEASE REQUIRING HEMODIALYSIS
- (2017) K Zomorodi et al. SLEEP
- 0642 A PHASE 3, RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND, MULTICENTER, 12-WEEK STUDY OF THE SAFETY AND EFFICACY OF JZP-110 IN THE TREATMENT OF EXCESSIVE SLEEPINESS IN PATIENTS WITH OBSTRUCTIVE SLEEP APNEA: SF-36 AND EQ-5D-5L MEASURES
- (2017) H Benes et al. SLEEP
- 0638 FUNCTION AND WORK PRODUCTIVITY MEASURES IN A PHASE 3, RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND, MULTICENTER, 12-WEEK STUDY OF THE SAFETY AND EFFICACY OF JZP-110 FOR THE TREATMENT OF EXCESSIVE SLEEPINESS IN PATIENTS WITH OBSTRUCTIVE SLEEP APNEA
- (2017) R Bogan et al. SLEEP
- 0644 A PHASE 3, PLACEBO-CONTROLLED, RANDOMIZED-WITHDRAWAL, DOUBLE-BLIND, 6-WEEK MULTICENTER STUDY OF THE SAFETY AND EFFICACY OF JZP-110 FOR THE TREATMENT OF EXCESSIVE SLEEPINESS IN PARTICIPANTS WITH OBSTRUCTIVE SLEEP APNEA
- (2017) PJ Strollo et al. SLEEP
- 0641 A PHASE 3, RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND, 12-WEEK, MULTICENTER STUDY OF THE EFFICACY AND SAFETY OF JZP-110 FOR THE TREATMENT OF EXCESSIVE SLEEPINESS IN PATIENTS WITH OBSTRUCTIVE SLEEP APNEA
- (2017) PK Schweitzer et al. SLEEP
- Pharmacotherapy of Apnea by Cannabimimetic Enhancement, the PACE Clinical Trial: Effects of Dronabinol in Obstructive Sleep Apnea
- (2017) David W Carley et al. SLEEP
- Rebound Hypersomnolence, Stimulant Abuse, and DAT-Mediated Dopamine Release
- (2017) Seiji Nishino SLEEP
- The Effect of CPAP in Normalizing Daytime Sleepiness, Quality of Life, and Neurocognitive Function in Patients with Moderate to Severe OSA
- (2017) Nick A. Antic et al. SLEEP
- A new era of disease modeling and drug discovery using induced pluripotent stem cells
- (2016) Wonhee Suh ARCHIVES OF PHARMACAL RESEARCH
- Effects of Modafinil and Armodafinil in Patients With Obstructive Sleep Apnea: A Meta-analysis of Randomized Controlled Trials
- (2016) Yi-Chun Kuan et al. CLINICAL THERAPEUTICS
- Pitolisant: First Global Approval
- (2016) Yahiya Y. Syed DRUGS
- Induced pluripotent stem cell technology: a decade of progress
- (2016) Yanhong Shi et al. NATURE REVIEWS DRUG DISCOVERY
- Obstructive Sleep Apnea: A Cluster Analysis at Time of Diagnosis
- (2016) Sébastien Bailly et al. PLoS One
- Effect of Oral JZP-110 (ADX-N05) on Wakefulness and Sleepiness in Adults with Narcolepsy: A Phase 2b Study
- (2016) Chad Ruoff et al. SLEEP
- Pharmacotherapy for residual excessive sleepiness and cognition in CPAP-treated patients with obstructive sleep apnea syndrome: A systematic review and meta-analysis
- (2016) Ariane B.C.C. Avellar et al. SLEEP MEDICINE REVIEWS
- Meta-analysis of randomised controlled trials of oral mandibular advancement devices and continuous positive airway pressure for obstructive sleep apnoea-hypopnoea
- (2016) Linda D. Sharples et al. SLEEP MEDICINE REVIEWS
- Effect of Oral JZP-110 (ADX-N05) on Wakefulness and Sleepiness in Adults with Narcolepsy: A Phase 2b Study
- (2016) Chad Ruoff et al. SLEEP
- Phenotypes of comorbidity in OSAS patients: combining categorical principal component analysis with cluster analysis
- (2015) George D. Vavougios et al. JOURNAL OF SLEEP RESEARCH
- Effect of oral JZP-110 (ADX-N05) treatment on wakefulness and sleepiness in adults with narcolepsy
- (2015) Richard K. Bogan et al. SLEEP MEDICINE
- Hypoglossal nerve stimulation in the treatment of obstructive sleep apnea: A systematic review and meta-analysis
- (2014) Victor F. Certal et al. LARYNGOSCOPE
- The promise of translational and personalised approaches for paediatric obstructive sleep apnoea: an ‘Omics’ perspective
- (2014) Hui-Leng Tan et al. THORAX
- Increased Prevalence of Sleep-Disordered Breathing in Adults
- (2013) P. E. Peppard et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- Oropharyngeal Crowding and Obesity as Predictors of Oral Appliance Treatment Response to Moderate Obstructive Sleep Apnea
- (2013) Satoru Tsuiki et al. CHEST
- Residual sleepiness in sleep apnea patients treated by continuous positive airway pressure
- (2013) Merce Gasa et al. JOURNAL OF SLEEP RESEARCH
- Pitolisant versus placebo or modafinil in patients with narcolepsy: a double-blind, randomised trial
- (2013) Yves Dauvilliers et al. LANCET NEUROLOGY
- Alertness and psychomotor performance effects of the histamine-3 inverse agonist MK-0249 in obstructive sleep apnea patients on continuous positive airway pressure therapy with excessive daytime sleepiness: a randomized adaptive crossover study
- (2013) W. Joseph Herring et al. SLEEP MEDICINE
- The histamine H3 receptor: from discovery to clinical trials with pitolisant
- (2011) Jean-Charles Schwartz BRITISH JOURNAL OF PHARMACOLOGY
- Predictors of long-term compliance with continuous positive airway pressure
- (2010) M. Kohler et al. THORAX
- The phenotype and genotype of adult obstructive sleep apnoea/hypopnoea syndrome
- (2009) R. L. Riha et al. EUROPEAN RESPIRATORY JOURNAL
- Predictors of residual sleepiness in adequately treated obstructive sleep apnoea patients
- (2009) I. Koutsourelakis et al. EUROPEAN RESPIRATORY JOURNAL
- Prevalence of residual excessive sleepiness in CPAP-treated sleep apnoea patients: the French multicentre study
- (2009) J-L. Pepin et al. EUROPEAN RESPIRATORY JOURNAL
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started